S&P has also affirmed its “A+” ratings on St. Luke’s other existing bonds.
“We assessed St. Luke’s enterprise profile as strong characterized by overall favorable demographics in a large primary service area, high-quality health metrics and a stable management and governance structure,” said S&P credit analyst Jennifer Soule.
St. Luke’s also faces several challenges, including its minority market share in a competitive service area that includes two large competing health systems.
The outlook is stable, reflecting S&P’s two-year view of St. Luke’s solid operations, healthy cash flow and stable position in a demographically favorable primary service area.
More articles on finance:
Average point-of-service collections increase to $1.8M in FY 2014: 4 things to know
Universal Health Services profit jumps 81.5% despite charity care growth
Study: Nonprofit hospitals need to improve charity care policies to meet ACA rules
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
